WINDTREE THERAPEUTICS INC /DE/ Quarterly Depreciation in USD from Q1 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Windtree Therapeutics Inc /De/ quarterly/annual Depreciation history and growth rate from Q1 2018 to Q1 2024.
  • Windtree Therapeutics Inc /De/ Depreciation for the quarter ending March 31, 2024 was $21K, a 8.7% decline year-over-year.
  • Windtree Therapeutics Inc /De/ annual Depreciation for 2023 was $82K, a 84.6% decline from 2022.
  • Windtree Therapeutics Inc /De/ annual Depreciation for 2022 was $533K, a 178% increase from 2021.
  • Windtree Therapeutics Inc /De/ annual Depreciation for 2021 was $192K, a 14.3% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $21K -$2K -8.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 $23K -$377K -94.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 $400K +$355K +789% Jan 1, 2022 Mar 31, 2022 10-K 2024-04-16
Q1 2021 $45K +$3K +7.14% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $42K -$8K -16% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 $50K +$9K +22% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q1 2018 $41K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.